stockportfolio.pro
Stocks / DVA vs SNN
DVA vs SNN
DaVita Inc. and Smith & Nephew plc side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| DaVita Inc. (DVA) | Smith & Nephew plc (SNN) | |
|---|---|---|
| Market cap | $12.7B | $12.9B |
| Revenue (latest FY) | $13.64B | $6.16B |
| Net income (latest FY) | $746.80M | $625.00M |
| Revenue growth (5y CAGR) | 3.4% | 5.7% |
| Net margin | 5.5% | 10.1% |
| Return on equity | -114.7% | 11.8% |
| P/E ratio | 19.1 | 21.3 |
| Dividend yield | — | 2.5% |
| Profitable years (of last 10) | 10 | 4 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open DVA — free Open SNN — freeFrequently asked questions
Which is bigger, DVA or SNN?
Smith & Nephew plc is larger by market capitalization — $12.9B versus $12.7B.
Which grows faster, DVA or SNN?
Over the last five fiscal years, Smith & Nephew plc grew revenue faster — 5.7%/yr versus 3.4%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.